[HTML][HTML] Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study
AA Lammertsma, AJ Poot, PR Schober, RC Schuit… - EJNMMI research, 2020 - Springer
Introduction Only a subgroup of non-small cell lung cancer (NSCLC) patients benefit from
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
[PDF][PDF] Quantification of [18 F] afatinib using PET/CT in NSCLC patients: a feasibility study
EA van de Stadt, M Yaqub, AA Lammertsma… - 2020 - scholarlypublications …
Introduction: Only a subgroup of non-small cell lung cancer (NSCLC) patients benefit from
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
Quantification of [18F] afatinib using PET/CT in NSCLC patients: a feasibility study
EA van de Stadt, M Yaqub… - EJNMMI …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Only a subgroup of non-small cell lung cancer (NSCLC) patients benefit from
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
[HTML][HTML] Quantification of [18F] afatinib using PET/CT in NSCLC patients: a feasibility study
EA van de Stadt, M Yaqub, AA Lammertsma… - EJNMMI …, 2020 - ncbi.nlm.nih.gov
Methods [18 F] Afatinib PET scans were performed in 10 NSCLC patients. The first patient
was scanned for the purpose of dosimetry. Subsequent patients underwent a 20-min …
was scanned for the purpose of dosimetry. Subsequent patients underwent a 20-min …
[PDF][PDF] Quantification of 18F-afatinib using PET/CT in NSCLC patients, a feasibility study
EA van de Stadt, M Yaqub, AA Lammertsma, AJ Poot… - NSCLC - research.vu.nl
Introduction: Only a subgroup of non-small cell lung cancer (NSCLC) patients benefit from
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
Quantification of [18F] afatinib using PET/CT in NSCLC patients: a feasibility study: a feasibility study
EA van de Stadt, M Yaqub… - EJNMMI …, 2020 - researchinformation.amsterdamumc …
Introduction: Only a subgroup of non-small cell lung cancer (NSCLC) patients benefit from
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study.
EA van de Stadt, M Yaqub… - EJNMMI …, 2020 - search.ebscohost.com
Introduction: Only a subgroup of non-small cell lung cancer (NSCLC) patients benefit from
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
Quantification of [. sup. 18F] afatinib using PET/CT in NSCLC patients: a feasibility study.
EA van de Stadt, M Yaqub, AA Lammertsma… - EJNMMI …, 2020 - go.gale.com
Introduction Only a subgroup of non-small cell lung cancer (NSCLC) patients benefit from
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
treatment using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) …
Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study.
EA van de Stadt, M Yaqub, AA Lammertsma… - EJNMMI …, 2020 - europepmc.org
Methods [18 F] Afatinib PET scans were performed in 10 NSCLC patients. The first patient
was scanned for the purpose of dosimetry. Subsequent patients underwent a 20-min …
was scanned for the purpose of dosimetry. Subsequent patients underwent a 20-min …
Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study
EA van de Stadt, M Yaqub, AA Lammertsma… - EJNMMI …, 2020 - search.proquest.com
Methods [18 F] Afatinib PET scans were performed in 10 NSCLC patients. The first patient
was scanned for the purpose of dosimetry. Subsequent patients underwent a 20-min …
was scanned for the purpose of dosimetry. Subsequent patients underwent a 20-min …